Avingtrans plc Employee & PDMR Share Incentive Awards

AVG

Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that on 21 November 2023, the Board of Avingtrans, in accordance with the Company’s Share Option Plan, granted options over 606,000 ordinary shares of 5p each in the Company with an exercise price of 390.0 pence per Ordinary Share. The following Option Awards were granted to Directors:

DirectorNumber of Ordinary Shares subject to Option Awards
Steve McQuillan180,000
Stephen King160,000

Furthermore Austen Adams, Managing Director of the Group’s PSRE Division and a PDMR of the Company, has been granted Option Awards over a total of 110,000 Ordinary Shares.

The Option Awards may not be exercised until 3 years from the date of grant and are subject to a performance condition, being the increase in the Company’s adjusted EPS must be at least equal to the increase in RPI over the vesting period.

Avingtrans plc designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Avingtrans CEO Steve McQuillan on record revenue, nuclear demand and medical imaging progress

Avingtrans plc (LON: AVG) CEO Steve McQuillan discusses record revenue of £163 million, adjusted EBITDA exceeding £20 million, a strong order book and growing demand for nuclear engineering products.

Avingtrans plc: Record £163m Revenue, 90% Order Cover and Adaptix Nears Commercial Breakthrough

Avingtrans CEO Steve McQuillan discusses record £163m revenue, more than 90% order coverage and growing nuclear opportunities, while Adaptix moves from regulatory approvals towards commercial orthopaedic sales.

Avingtrans reports record revenue and strong profit growth as AI and nuclear demand builds

Avingtrans reported record revenue of £163.3m for FY2026, with adjusted EBITDA rising 24% to £20.7m as strong demand across AI infrastructure, data centres, electrification and nuclear power supported growth.

Avingtrans acquires US nuclear specialist Joseph Oat for $2.5m

Avingtrans has acquired the intellectual property, trading history and brand of US nuclear engineering specialist Joseph Oat for $2.5m, expanding its nuclear capabilities and access to legacy equipment across the US power sector.

Adaptix expands US distribution with Digital X-Ray Technologies partnership

Adaptix has appointed Digital X-Ray Technologies as a US distributor for the Ortho350, expanding access to its 3D orthopaedic imaging system across the West Coast and Pacific Islands.

Booth Industries strengthens infrastructure credentials with completed Silvertown Tunnel project

Booth Industries completed a circa £1.3 million Silvertown Tunnel contract in 2024, supplying and installing 25 specialist fire and pressure-resistant doorsets.

Search